Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Researchers shed light on a key molecular switch in T helper cells

Defects in immune system cells called T helper cells may lead to diseases characterized by a faulty inflammatory response such as autoimmunity and asthma. Understanding the molecular steps involved in how T helper cells mature may help researchers develop treatments for these diseases.

17 Oct 2005

Gut antibody could prove to be a promising drug target for Crohn's disease

A collaboration led by the Burnham Institute for Medical Research has found that an antibody which binds to an unusual sugar molecule residing in the gut halts the inflammation seen in Crohn's disease and other intestinal inflammations. The antibody could prove to be a promising drug target for these common chronic intestinal disorders.

9 Oct 2005

Gaps in the intestinal barrier could be a cause of inflammatory diseases of the gut such as Crohn's Disease

Their research, led by Professor Alastair Watson in the University's Faculty of Medicine, could have important implications for the treatment of patients with diseases like Crohn's - an inflammatory bowel disorder that causes severe ulceration in the intestine, leading to pain, bleeding and diarrhoea.

20 Sep 2005

Parasite could help prevent asthma

Asthma in Britain has reached epidemic proportions and the country now has one of the highest numbers of sufferers of the allergy in the world; in Ireland alone it is reported that as many as 30% of all schoolchildren have symptoms of the disease.

5 Sep 2005

Hundreds of identified genes involved in the pathophysiology of ulcerative colitis and Crohn disease

In a paper published in PLoS Medicine researchers from the German Genome Research Network have analysed the expression of thousands of genes from patients with inflammatory bowel disease (ulcerative colitis and Crohn disease) using a genome wide approach to produce a comprehensive picture of which genes are activated in these conditions.

24 Aug 2005

Potential new target for cannabis-derived drugs as a treatment of inflammatory bowel disease

Researchers investigating anecdotal evidence that cannabis relieves some of the symptoms of inflammatory bowel disease (IBD) have discovered a potential new target for cannabis-derived drugs for treatment of the disease.

2 Aug 2005

Cannabis drugs may benefit those with bowel disease

UK scientists say they believe that patients with inflammatory bowel disease may benefit from cannabis-based drugs.

1 Aug 2005

Pseudomonas aeruginosa has broken the immune system's code

The human opportunistic pathogen, Pseudomonas aeruginosa, has broken the immune system's code, report researchers from the University of Chicago, enabling the bacteria to recognize when its host is most vulnerable and to launch an attack before the weakened host can muster its defenses.

1 Aug 2005

Mixture of 8 bacteria (VSL#3) for 6 weeks helps ulcerative colitis

A mixture of bacteria developed in part by University of Alberta researchers has been proven highly effective in treating people suffering from ulcerative colitis.

25 Jul 2005

Researchers have identified a highly specific pathway that causes inflammation in lung tissue

...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.

30 Jun 2005

Stimulating innate immunity helps ease Crohn's disease symptoms

Like throwing oil on a fire or prescribing a high cholesterol diet for heart patients, gastroenterologists traditionally have believed that it would not be a good idea to stoke up the body's immune system to treat Crohn's disease.

26 May 2005

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

Ulcerative colitis affects about one out of every 2,000 Americans, and after living with the disease for 30 years, nearly 22 percent of those people will develop colon cancer.

16 May 2005

No link between MMR jab and Crohn's disease

A research paper published in 1998, which claimed the MMR jab was in some way linked to autism and Crohn's disease, the inflammatory bowel disease, caused MMR vaccination numbers to fall across the country.

12 May 2005

Maxim Pharmaceuticals issued patent for method of identifying therapeutically effective immunosupressive agents

Maxim Pharmaceuticals have announced the United States Patent and Trademark Office issued U.S. patent number 6,828,091 B2, entitled "Method of Identifying Immunosuppressive Agents."

23 Apr 2005

Fish oil, soluble fiber and antioxidants reduces need for traditional ulcerative colitis treatment

According to a study published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, a nutritionally complete oral supplement enriched with fish oil, soluble fiber and antioxidants reduces reliance on traditional therapies for people with ulcerative colitis.

6 Apr 2005

Self-reporting of symptoms by patients with ulcerative colitis better than assessing patients with endoscopy

People living with fatigue, abdominal discomfort and bloody diarrhea caused by the chronic inflammation of ulcerative colitis may no longer need to undergo frequent and uncomfortable endoscopies, a new study shows.

27 Feb 2005

Short girls with underlying disease are not being diagnosed

Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.

7 Feb 2005

Suffering from fatigue, abdominal discomfort or bloody diarrhea? Your doctor might not recommend an uncomfortable endoscopy

3 Feb 2005

Calcium and vitamin D treatment alone can improve bone mineral density in Crohn's patients

According to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, the addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.

1 Feb 2005

Biochip for detection of inflammatory bowel disease

At the III International Symposium on Advanced Therapy for Chronic Inflammatory Bowel Disease, held in Madrid, the biotechnological company, Progenika, presented a DNA-chip the purpose of which is the optimisation of the diagnosis, prognosis and treatment of patients with inflammatory bowel disease (Crohn’s disease and Ulcerous Colitis).

26 Jan 2005

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Researchers shed light on a key molecular switch in T helper cells

Gut antibody could prove to be a promising drug target for Crohn's disease

Gaps in the intestinal barrier could be a cause of inflammatory diseases of the gut such as Crohn's Disease

Parasite could help prevent asthma

Hundreds of identified genes involved in the pathophysiology of ulcerative colitis and Crohn disease

Potential new target for cannabis-derived drugs as a treatment of inflammatory bowel disease

Cannabis drugs may benefit those with bowel disease

Pseudomonas aeruginosa has broken the immune system's code

Mixture of 8 bacteria (VSL#3) for 6 weeks helps ulcerative colitis

Researchers have identified a highly specific pathway that causes inflammation in lung tissue

Stimulating innate immunity helps ease Crohn's disease symptoms

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

No link between MMR jab and Crohn's disease

Maxim Pharmaceuticals issued patent for method of identifying therapeutically effective immunosupressive agents

Fish oil, soluble fiber and antioxidants reduces need for traditional ulcerative colitis treatment

Self-reporting of symptoms by patients with ulcerative colitis better than assessing patients with endoscopy

Short girls with underlying disease are not being diagnosed

Suffering from fatigue, abdominal discomfort or bloody diarrhea? Your doctor might not recommend an uncomfortable endoscopy

Calcium and vitamin D treatment alone can improve bone mineral density in Crohn's patients

Biochip for detection of inflammatory bowel disease

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in